Cargando…

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy

Glycogen storage disease Ia (GSD Ia), also known as von Gierke disease, is caused by pathogenic variants in the G6PC1 gene (OMIM 232200) which encodes glucose‐6‐phosphatase. Deficiency of glucose‐6‐phosphatase impairs the processes of gluconeogenesis and glycogenolysis by preventing conversion of gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, David G., Koch, Rebecca L., Pendyal, Surekha, Benjamin, Robert, Kishnani, Priya S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494510/ https://www.ncbi.nlm.nih.gov/pubmed/37701330 http://dx.doi.org/10.1002/jmd2.12381

Ejemplares similares

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone
por: Wu, Shimin, et al.
Publicado: (2022)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
por: Haring, Martijn P.D., et al.
Publicado: (2022)

A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III
por: Hijazi, Ghada, et al.
Publicado: (2021)

"Bull’s eye” appearance of hepatocellular adenomas in patients with glycogen storage disease type I — atypical magnetic resonance imaging findings: Two case reports
por: Vernuccio, Federica, et al.
Publicado: (2021)

A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report
por: Yin, Maohui, et al.
Publicado: (2022)

Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report
por: Dagdelen, Selcuk, et al.
Publicado: (2008)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia
por: Lee, Young Mok, et al.
Publicado: (2015)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Characterization of a canine model of glycogen storage disease type IIIa
por: Yi, Haiqing, et al.
Publicado: (2012)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV
por: Yi, Haiqing, et al.
Publicado: (2016)

Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report
por: Cohn, Aviva, et al.
Publicado: (2017)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

A Novel Mutation in a Newborn Baby Leading to Glycogen Storage Disease Type Ia
por: Dorum, S, et al.
Publicado: (2018)

Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia
por: Perry, Ariane, et al.
Publicado: (2020)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?
por: El-Gharbawy, Areeg, et al.
Publicado: (2022)

Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III
por: Young, Sarah P., et al.
Publicado: (2020)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
por: Cho, Jun-Ho, et al.
Publicado: (2017)

Double filtration plasmapheresis for pregnancy with hyperlipidemia in glycogen storage disease type Ia: A case report
por: Wang, Jie, et al.
Publicado: (2022)

Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis
por: Sato, Hirotaka, et al.
Publicado: (2022)

A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature
por: Ai, Jiaoyu, et al.
Publicado: (2020)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Glycogen storage disease type Ia misdiagnosed as multiple acyl-coenzyme A dehydrogenase deficiency by mass spectrometry
por: Du, Juan, et al.
Publicado: (2022)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia
por: Zheng, Bi-Xia, et al.
Publicado: (2014)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report
por: Wang, Wenying, et al.
Publicado: (2019)

Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
por: Resaz, Roberta, et al.
Publicado: (2021)

Yap signalling regulates ductular reactions in mice with CRISPR/Cas9-induced glycogen storage disease type Ia
por: Xie, Yixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_stgiuu83eumtn0lh7nggltrnjv